Justices Send Back Gene Case; New York Times, 3/26/12

Andrew Pollack, New York Times; Justices Send Back Gene Case:

"The Supreme Court on Monday ordered an appeals court to reconsider its decision to uphold patents held by Myriad Genetics on two genes associated with a high risk of breast and ovarian cancer.

The appeals court was told to take another look at the case in light of the Supreme Court’s ruling last week that a certain diagnostic test was not eligible for patents because it was a simple application of a law of nature.

The case, Association for Molecular Pathology v. Myriad Genetics, No. 11-725, is being closely watched because it involves the ethically charged but commercially important question of whether genes can be patented."